INTELLIA THERAPEUTICS, INC. — Net Income by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/c982c77a-843e-4ced-870c-b398426ab7b3/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-412.7M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-076550 |
| FY 2024 | $-519.0M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-029007 |
| FY 2023 | $-481.2M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-018736 |
| FY 2022 | $-474.2M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-004097 |
| FY 2021 | $-267.9M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-001981 |
| FY 2020 | $-134.2M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-009011 |
| FY 2019 | $-474.2M | 2019-01-01 – 2019-12-31 | evidence 0000950170-23-004097 |
| FY 2018 | $-85.3M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-004680 |
| FY 2017 | $-67.5M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-005544 |
| FY 2016 | $-31.6M | 2016-01-01 – 2016-12-31 | evidence 0001193125-17-082186 |
| FY 2015 | $-12.4M | 2015-01-01 – 2015-12-31 | evidence 0001193125-17-082186 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
INTELLIA THERAPEUTICS, INC. — all facts · Revenue · Operating Income